Selected Publications
Thacker G, Henry S, Nandi A, Debnath R, Singh S, Nayak A, Susnik B, Boone MM, Zhang Q, Kesmodel SB, Gumber S, Das GM, Kambayashi T, Dos Santos CO, Chakrabarti R.: Immature natural killer cells promote progression of triple-negative breast cancer. Sci Transl Med 15 (686): 2023.
Adam A Kraya, Kara N Maxwell, Monika A Eiva, Bradley Wubbenhorst, John Pluta, Michael Feldman, Anupma Nayak, Daniel J Powell Jr, Susan M Domchek, Robert H Vonderheide, Katherine L Nathanson: PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer JCO Precis Oncol
: 2023.
Khoury T, Rosa M, Nayak A, Karabakhtsian R, Fadare O, Li Z, Turner B, Fang Y, Kumarapeli A, Li X, Numbere N, Villatoro T, Wang JG, Sadeghi S, Attwood K, George A, Bhargava R.: Clinicopathologic Predictors of Clinical Outcomes in Mammary Adenoid Cystic Carcinoma: A Multi-institutional Study. Modern Pathology 36 (2): 2023.
Kara Maxwell, et al.: Biallelic BRCA loss and homologous recombination deficiency in non-breast/ovarian tumors in germline BRCA1/2 carriers JCO Precision Oncology : 2023.
Shah JB, Pueschl D, Wubbenhorst B, Fan M, Pluta J, D'Andrea K, Hubert AP, Shilan JS, Zhou W, Kraya AA, Llop Guevara A, Ruan C, Serra V, Balmaña J, Feldman M, Morin PJ, Nayak A, Maxwell KN, Domchek SM, Nathanson KL.: Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nat Commun. 13 (1): 2022.
Ajeya Nandi, Rahul Debnath, Anupma Nayak, Tsun Ki Jerrick To, Gatha Thacker, Megan Reilly, Sanjeev Gumber, Ilias Karagounis, Ning Li, Christopher J Lengner, Malay Haldar, Alana L Welm, Andres M Blanco, Christoforos Thomas, Rumela Chakrabarti: Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer Cancer Res 82 (20): 3718-3733,2022.
Anna Budina, Sahar J Farahani, Priti Lal, Anupma Nayak: Subcategorization of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens for Predicting Progression Arch Pathol Lab Medicine 146 (9): 1131-1139,2022.
Emily A Verbus, Alexander J Rossi, Amy S Clark, Neil K Taunk, Anupma Nayak, Jonathan M Hernandez, Julia C Tchou: Preoperative Use of a Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer Ann Surg Oncol 29 (3): 1530-1532,2022.
Adeseye Adekeye, Divyansh Agarwal, Anupma Nayak, Julia Tchou: PTGES3 is a Putative Prognostic Marker in Breast Cancer J Surg Res
271 : 154-162,2022.
Sarkis Hamalian, Robert Güth, Farhana Runa, Francesca Sanchez, Eric Vickers, Megan Agajanian, Justin Molnar, Tuan Nguyen, Joshua Gamez, Jonathan D Humphries, Anupma Nayak, Martin J Humphries, Julia Tchou, Ioannis K Zervantonakis, Jonathan A Kelber: A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers Oncogene : 2021.
View all publications
Academic Contact Information
Associate Professor
Dept. of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
Perelman School of Medicine
3400 Spruce St.
6 Founders
Philadelphia,
PA
19104
Phone: 215-662-4899